联合应用α_1-肾上腺素能受体和毒蕈碱受体拮抗剂治疗下泌尿系症状
出处
《医学临床研究》
CAS
2008年第1期105-107,共3页
Journal of Clinical Research
参考文献12
-
1Graham RM,Perez DM, Hwa J, a al. Alphal-adrenergic receptor subtypes, molecular structure, function and signaling [J]. Grc Res ,1996,78:737-749.
-
2Nasu K, Moriyama N, Kawate K,et al . Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate., comparison of benign hypertrophied tissue and nonhypertrophied tissue[J]. Br J Pharmacol , 1996,119:797- 803.
-
3Yoshimura N,Sasa M, Ohno Y, a al . Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus[J]. J Urol ,1988,139:423-426.
-
4Caulfield MP, Birdsall NJ. International union of pharmacology,SVII. Classification of muscarinic acetylcholine receptors[J]. Pharmacol Rev ,1998,50:279-290.
-
5Athenasopoula A, Gyftopoulos K, Giannitsas; K, a al. Comlination treatment with an a-blocker plus an anticholinergic for bladder outlet obstruction., a prospective, randomized, controlled study[J]. J Urol ,2003,169-2253-2256.
-
6Serels S, Stein M. Prospective study comparing hyoseyamine, doxazosin,and combination therapy for the treatment of urgency and freguancy in women[J]. Neurourol Urodyn , 1998, 17:31-34.
-
7Abrams P. Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety[J]. J Urol , 2002,167(Suppl) : 226 (abstract 1048).
-
8Lee JY,Kin HW,Lee SJ, et al . Comparison of doxazosin with or without toherodine in men with symptomatic bladder outlet obstruction and an overactive bladder [J]. BJU Int , 2004, 817-820.
-
9Kaplan SA,Walmsley K,Te AE, et al . Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers[J]. J Urol ,2004,171(Suppl):243,(abstract 917).
-
10Ruggieri MR, Braverman AS,Pontari MA. Combined use of α- adrenergic and muscarinic antagonists for the treatment of voiding dysfunction[J]. J Urol ,2005,174(5):1743-1748.
二级参考文献3
-
1瞿创予,郑家富,马永江,钱松溪.苄胺唑啉尿道压力分布试验及其意义[J].临床泌尿外科杂志,1995,10(2):106-107. 被引量:9
-
2孙颖浩,卫中庆,郑家富,瞿创予,钱松溪,许传亮,马永江.改良法苄胺唑啉尿道压力分布试验的临床意义[J].中华泌尿外科杂志,1998,19(9):548-550. 被引量:10
-
3瞿创予,马永江.非神经源性尿道内括约肌痉挛综合征:附20例报告[J].中华泌尿外科杂志,1992,13(3):210-212. 被引量:8
共引文献20
-
1梁秀山.良性前列腺增生症的治疗现状[J].中国医药导报,2010,7(23):12-14. 被引量:17
-
2黄东平,王仁顺.多沙唑嗪治疗下泌尿系症状和前列腺增生的现状与进展[J].医学临床研究,2005,22(3):389-392. 被引量:6
-
3赵黎明,任素琴,孔曲,吴青.联合用药治疗良性前列腺增生的疗效观察及健康教育对策[J].现代护理,2005,11(13):1042-1043.
-
4程祝忠,陈君辉,文华长,许国辉.前列腺增生的动脉栓塞治疗进展[J].四川医学,2005,26(8):896-897. 被引量:3
-
5吕坚伟,周立新,冷静,黄翼然,唐涌志,汤海,闵志廉,高轶.萘哌地尔与盐酸特拉唑嗪治疗良性前列腺增生的疗效与安全性评估[J].中国男科学杂志,2005,19(5):36-39. 被引量:20
-
6汤金荣,徐云林.非那雄胺、α_1受体阻滞剂联合治疗前列腺增生[J].中原医刊,2006,33(19):42-43. 被引量:3
-
7周乐友.阿呋唑嗪治疗症状性前列腺增生[J].医学临床研究,2007,24(3):510-512.
-
8张乾驰,蒋善群,毛广运,王玉,徐希平.特拉唑嗪和氨氯地平联合用药与单一用药对中老年男性良性前列腺增生患者膀胱出口梗阻和生活质量改善的有效性比较[J].中国组织工程研究与临床康复,2007,11(47):9517-9520.
-
9张柯萍,潘雪英.α_1肾上腺素受体拮抗剂的研究进展[J].海峡药学,2008,20(5):4-6. 被引量:1
-
10郑军,邓晓洪,欧平,王元中.盐酸坦索罗辛治疗BPH的长期疗效观察[J].临床泌尿外科杂志,2009,24(3):239-240. 被引量:14
-
1刘建光,杨进益,魏伟.输尿管硬镜在门诊手术中的应用[J].中国误诊学杂志,2011,11(21):5110-5110.
-
2李新.坦索罗辛治疗输尿管下段结石的临床疗效观察[J].医学临床研究,2009,26(4):661-662.
-
3王翔,邓耀良.BPH相关的下尿路症状的药物治疗[J].国际泌尿系统杂志,2015,35(2):309-314.
-
4杨泽松(综述),叶烈夫(审校).坦索罗辛治疗输尿管下段结石的研究进展[J].国际泌尿系统杂志,2010(1):76-79.
-
5黄启敏,李宏,黄达飞,周青英.糖尿病大鼠膀胱超微结构改变及毒蕈碱受体基因表达的研究[J].温州医学院学报,2009,39(3):269-271.
-
6陈卫红,刘军,王元林,孙兆林,朱建国.52例α1受体阻滞剂在输尿管上段结石体外冲击波碎石术后的应用[J].重庆医学,2012,41(1):40-41. 被引量:11
-
7孙耀飞(综述),方祖军(审校).抗毒蕈碱药物治疗膀胱过度活动症的研究进展[J].国际泌尿系统杂志,2010,30(3):342-345.
-
8章卫康,刘锦霞.钙离子拮抗剂治疗对冲性颅脑损伤的临床分析[J].右江医学,2000,28(6):443-444.
-
9易憬,熊飞,苏良平,李庭庭,陈登,杨兵,张盛龙,张宝珍,刘长.23例腺性膀胱炎治疗体会[J].西部医学,2012,24(2):289-290. 被引量:2
-
10崔涛,梁金仙,胡延林.关于创伤性休克中内皮素作用的临床研究[J].中国医师进修杂志,2014,37(32):54-55.